# A Long-term Safety Study of Infliximab (Remicade)

> **NCT00261976** · — · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 2971 (actual)

## Conditions studied

- Arthritis, Rheumatoid
- Crohn Disease
- Psoriasis

## Interventions

- **DRUG:** Infliximab (Remicade)

## Key facts

- **NCT ID:** NCT00261976
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 2971 (ACTUAL)
- **Last updated:** 2014-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00261976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00261976, "A Long-term Safety Study of Infliximab (Remicade)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00261976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*